ArticleEuropean journal of nuclear medicine and molecular imaging2025

Low-dose temozolomide selectively increases glioblastoma's vascular permeability, tumor microenvironment penetration and the killing potential of systemic actinium-225 α-particle dendrimer-radioconjugates improving treatment efficacy.

Rajiv Ranjit Nair et al.PubMed ↗Publisher ↗

No numbers read from the abstract.